Skip to main content

Main menu

  • Home
  • Current Issue
  • Content
    • Current Issue
    • Early Access
    • Multimedia
    • Podcast
    • Collections
    • Past Issues
    • Articles by Subject
    • Articles by Type
    • Supplements
    • Plain Language Summaries
    • Calls for Papers
  • Info for
    • Authors
    • Reviewers
    • Job Seekers
    • Media
  • About
    • Annals of Family Medicine
    • Editorial Staff & Boards
    • Sponsoring Organizations
    • Copyrights & Permissions
    • Announcements
  • Engage
    • Engage
    • e-Letters (Comments)
    • Subscribe
    • Podcast
    • E-mail Alerts
    • Journal Club
    • RSS
    • Annals Forum (Archive)
  • Contact
    • Contact Us
  • Careers

User menu

  • My alerts

Search

  • Advanced search
Annals of Family Medicine
  • My alerts
Annals of Family Medicine

Advanced Search

  • Home
  • Current Issue
  • Content
    • Current Issue
    • Early Access
    • Multimedia
    • Podcast
    • Collections
    • Past Issues
    • Articles by Subject
    • Articles by Type
    • Supplements
    • Plain Language Summaries
    • Calls for Papers
  • Info for
    • Authors
    • Reviewers
    • Job Seekers
    • Media
  • About
    • Annals of Family Medicine
    • Editorial Staff & Boards
    • Sponsoring Organizations
    • Copyrights & Permissions
    • Announcements
  • Engage
    • Engage
    • e-Letters (Comments)
    • Subscribe
    • Podcast
    • E-mail Alerts
    • Journal Club
    • RSS
    • Annals Forum (Archive)
  • Contact
    • Contact Us
  • Careers
  • Follow annalsfm on Twitter
  • Visit annalsfm on Facebook
Meeting ReportPatient education/adherence

Reasons for Nonadherence to the Direct Oral Anticoagulant Apixaban: Cross-Sectional Survey of Atrial Fibrillation Patients

Derjung Tarn, Kevin Shih and Janice Schwartz
The Annals of Family Medicine January 2023, 21 (Supplement 1) 3456; DOI: https://doi.org/10.1370/afm.21.s1.3456
Derjung Tarn
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kevin Shih
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janice Schwartz
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • eLetters
  • Info & Metrics
  • PDF
Loading

Abstract

Context: Nonadherence to direct oral anticoagulants to prevent stroke occurs in up to 40% of patients with atrial fibrillation. Underlying reasons are not well understood.

Objectives: Quantify patient-reported reasons for nonadherence and identify potential strategies to improve adherence.

Study Design and Analysis: Cross-sectional survey.

Setting: 2 large academic health systems in Northern and Southern California.

Population Studied: Patients with atrial fibrillation who self-reported nonadherence to apixaban.

Instruments: The survey included questions about reasons for nonadherence to apixaban and an existing validated instrument assessing medication adherence.

Outcome Measure: Relationship between reasons for nonadherence and medication adherence scores (ranging from 0-100, with higher numbers indicating greater adherence) was assessed.

Results: Responses from 419 patients were analyzed. Patients’ mean age was 71.1 (SD=10), 41.5 % were women, and mean CHA2DS2VASc score was 3.2 (SD=1.6). About two-thirds had adherence scores >80 (acceptable adherence), and one-third had scores ≤80 (poor adherence). All groups cited forgetfulness as a contributor to nonadherence. Multivariable logistic regression showed that adherence score ≤80 was associated with: 1) not believing apixaban was needed (OR=2.5; p=0.003); 2) medication cost (OR=1.4; p=0.002); and 3) fear of severe bleeding (OR=1.2; p=0.02). Top strategies that patients with adherence scores ≤80 selected as helping “a great deal/a lot” to increase adherence included blood tests to evaluate efficacy (56%), physician counseling about adherence (55%), and having a reversal agent (39%). Notably, almost half of all patients did not disclose nonadherence to healthcare providers.

Conclusions: Patients may not disclose nonadherence to prescribers, and attitudes related to nonadherence to apixaban differ among patients with acceptable versus poor adherence. While all patients may benefit from strategies to address forgetfulness, concerns related to the purpose of apixaban, cost, and bleeding risk may require special attention in those with poor adherence.

  • © 2023 Annals of Family Medicine, Inc.
Previous
Back to top

In this issue

The Annals of Family Medicine: 21 (Supplement 1)
The Annals of Family Medicine: 21 (Supplement 1)
Vol. 21, Issue Supplement 1
1 Jan 2023
  • Table of Contents
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Annals of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Reasons for Nonadherence to the Direct Oral Anticoagulant Apixaban: Cross-Sectional Survey of Atrial Fibrillation Patients
(Your Name) has sent you a message from Annals of Family Medicine
(Your Name) thought you would like to see the Annals of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
6 + 9 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Reasons for Nonadherence to the Direct Oral Anticoagulant Apixaban: Cross-Sectional Survey of Atrial Fibrillation Patients
Derjung Tarn, Kevin Shih, Janice Schwartz
The Annals of Family Medicine Jan 2023, 21 (Supplement 1) 3456; DOI: 10.1370/afm.21.s1.3456

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Get Permissions
Share
Reasons for Nonadherence to the Direct Oral Anticoagulant Apixaban: Cross-Sectional Survey of Atrial Fibrillation Patients
Derjung Tarn, Kevin Shih, Janice Schwartz
The Annals of Family Medicine Jan 2023, 21 (Supplement 1) 3456; DOI: 10.1370/afm.21.s1.3456
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Silent, Urgent, Deadly: The Effects of a Patient Outreach Education Program on Shared Decision-making and Lung Cancer
  • Transitional Care Management care team impact on no-show rates to hospital discharge appointments
  • A brief theory driven patient education video to reduce potentially harmful regular over-the-counter NSAID use
Show more Patient education/adherence

Similar Articles

Content

  • Current Issue
  • Past Issues
  • Early Access
  • Plain-Language Summaries
  • Multimedia
  • Podcast
  • Articles by Type
  • Articles by Subject
  • Supplements
  • Calls for Papers

Info for

  • Authors
  • Reviewers
  • Job Seekers
  • Media

Engage

  • E-mail Alerts
  • e-Letters (Comments)
  • RSS
  • Journal Club
  • Submit a Manuscript
  • Subscribe
  • Family Medicine Careers

About

  • About Us
  • Editorial Board & Staff
  • Sponsoring Organizations
  • Copyrights & Permissions
  • Contact Us
  • eLetter/Comments Policy

© 2025 Annals of Family Medicine